Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Ondo Finance brings pre-IPO AI exposure on-chain — But there’s a catch

Ondo Finance brings pre-IPO AI exposure on-chain — But there’s a catch

AMBCryptoAMBCrypto2026/10/06 18:39

Ondo Finance made a reputation out of putting stocks and treasuries on-chain. Now, they want something more.

The platform is moving into private markets.

The latest launch: Ondo Private Markets

Let’s get one thing clear with this new launch. You’re not actually buying shares. You get tokenized notes.

@media only screen and (min-width: 0px) and (min-height: 0px) { div[id^="bsa-zone_1774359638628-7_123456"] { min-height: 50px; transition: min-height 0.3s ease; } } @media only screen and (min-width: 640px) and (min-height: 0px) { div[id^="bsa-zone_1774359638628-7_123456"] { min-height: 90px; } }
AD

Here’s how the payout works. The note’s eventual payout is linked to the value realised per common share when the referenced company undergoes a qualifying liquidity event. If the company does well, buyer does well. If it flops, so does the note.

There’s no shares with your name on them, and no say in how the company is run.

What you do get though, is freedom to move. Eligible investors can hold the notes in their own self-custody wallets or trade them on secondary markets.

The first notes start trading this week.

Ondo has done this before… with public companies. Ondo Stocks lists more than 450 US stocks and ETFs; holds over $1 billion in TVL.

Private markets are the next room over, but its getting crowded.

In April, Robinhood’s venture fund put $75 million into OpenAI common stock. They opened it up to retail investors through a publicly traded closed-end fund. In June, Citi was reported to be building a blockchain marketplace for private-company shares.

ONDO holds above $0.50 after a 50% run in September

The token itself has had a decent few weeks. ONDO at press time was at $0.507; that’s about 50% above its mid-September low near $0.33!

The top didn’t last, though.

ONDO tagged about $0.61 on the 28th, then fell back. The token has since been moving sideways.

RSI was still in bullish territory but below its signal line at 63. OBV also peaked near 365 million during the rally, dropped, and has since crept back to 329 million. Some buyers left, a few are returning.

If the new notes pull real volume this week, $0.55 is the first level worth watching. If they don’t, $0.48 is where things get uncomfortable.

Final Summary

  • Ondo Finance launched Ondo Private Markets; there’s tokenized notes tied to an unnamed pre-IPO AI company.
  • ONDO hasn’t reacted much since the announcement; $0.55 and $0.48 are key levels.
News Image 0News Image 1
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

路透社•2026/10/09 04:26
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low

UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.

智通财经•2026/10/09 03:53